Curriculum Vitae
ORCID: https://orcid.org/-
Google Scholar: https://scholar.google.pt/citations?user=0tuzHsIAAAAJ&hl=pt-PT
After joining the Gulbenkian PhD Program, I moved to the Institut Pasteur in Paris, where in 2001
I defended a PhD thesis in Immunology ("Mention Très Honorable avec Félicitations du Jury").
Subsequently, I worked at The Rockefeller University in New York, first as a postdoc and then as
a research associate. In 2008, I became a principal investigator at the Instituto Gulbenkian de
Ciência (IGC), under a “Ciência” contract. At the IGC, I graduated 3 PhD students. In 2015, I
moved to the Nova Medical School, CEDOC, under an IF investigator contract. I have
independently secured 5 competitive grants amounting a total of 605 000 € and also an additional
FCT grant as collaborator. In 2013, I published my first 2 articles as senior/corresponding author,
and in 2014 I published in Nature Communications what I consider to be my best work so far.
Since the late 90s, I have been exploring the two hallmarks of the immunoglobulin (Ig) genes,
allelic exclusion and somatic DNA editing, as stepping stones to gain genetic and quantitative
insights into related and broader fields, namely the epigenetics of mono-allelic expression and the
interplay between the B-cell DNA editing enzymes and DNA repair. I maintain a long-term
interest in all processes related to the editing of the immunogloubulin genes, DNA repair and the
genetic bases of cancer. I approach these phenomena from both evolutionary and mechanistic
angles, relying mostly on molecular and cellular biology.
EDUCATION
2001
Ph.D. in Immunology from the Université de Paris VI, France (mention très
honorable avec les félicitations du jury).
1996
“Masters” from the Programa Gulbenkian de Doutoramento em Biologia e
Medicina.
1994
Degree in Biology (final score 17.4/ 20) from the Faculdade de Ciências da
Universidade de Lisboa.
PROFESSIONAL APPOINTMENTS
2018Invited assistant professor, Nova Medical School
2015FCT investigator (Development Grant level). Principal investigador at CEDOC,
Portugal).
2008Principal Investigator at the Instituto Gulbenkian de Ciência, Portugal.
2006-7
Research Associate at the Rockefeller University, New York, USA.
2001-6
Postdoctoral Associate at the Rockefeller University, New York, USA.
2005
Invited assistant professor, Faculdade de Medicina de Lisboa, Portugal.
TEACHING EXPERIENCE
2018
Invited assistant professor at Nova Medical School.
2017-8
Faculty of the Nova Biological Research Masters, Nova Medical School.
2016
Invited speaker at “Epigenetics - from mechanisms to disease”. Instituto de
Investigação em Ciências da Vida e Saúde (ICVS), Braga, Portugal.
Invited speaker at the Immunology Course of the GABBA PhD Program, Porto,
Portugal. http://gabba.up.pt
Module organizer in the Graduate Programme Science for Development.
2015
2014
-
http://pages.igc.gulbenkian.pt/pgcd/en
Module organizer in the Graduate Programme Science for Development.
http://pages.igc.gulbenkian.pt/pgcd/en
Lecture in the module Fronteiras da Investigação (FCUL), Lisboa, Portugal.
Invited speaker at the Immunology Course of the GABBA PhD Program, Porto,
Portugal. http://gabba.up.pt
Invited
Speaker
at
the
PGCD
–Praia,
Cabo
Verde.
http://pages.igc.gulbenkian.pt/pgcd/en
Invited speaker at the Immunology Course of the GABBA PhD Program, Porto,
Portugal. http://gabba.up.pt
Organizer of the workshop “RAG proteins and receptor diversity" (GABBA
graduate program, Porto).
Co-organizer of the Course “Hypothesis-driven Research”, at the Instituto
Gulbenkian de Ciência.
http://www.igc.gulbenkian.pt/pages/facilities.php/A=232___collection=article
Invited speaker at the Fiocruz-Yakult, 1st International Course, Salvador, Brazil.
Invited speaker at the Immunology Course of the Gulbenkian PhD Program, Oeiras,
Portugal.
Invited speaker at the Immunology Course of the GABBA PhD Program, Porto,
Portugal.
Lectures on basic immunology to 2nd year MD students from the Faculdade de
Medicina de Lisboa, Portugal.
STUDENTS
2017
Masters’ supervisor of Manuel Vicente (graduated with a 19/20 score).
2015
PhD thesis defence of Inês Trancoso: “… The quality of the experimental design
and of the results obtained is excellent. The presentation of the wor both in the
thesis and during the defence was outstanding, as well as the candidate’s capacity
to discuss her results. Therefore, we fully support the award of the Ph.D.” Dr.
Silvo Conticello and Dr. Almudena Ramiro, main opponents.
2014
PhD thesis defence of Clara F. Pereira The thesis work of Clara Pereira represents
a step forward in the understanding of a fundamental process in B lymphocyte
differentiation (…). Clara Pereira has done ambitious and original experimentation,
and demonstrated in gthe discussion her profound knowledge of this complicated
and controversial research field, as well as her independent thinking about it.” Dr.
Dinis Calado and Professor Klaus Rajewsky, main opponents.
2013
PhD thesis defense of Thiago S. Guzella “… His theoretical approach is original
and carefully pursued including measurements and analysis of T-cell systems. His
presentation was very crisp and he defended his thesis with vigour in a satisfying
manner. Taken together, his contributions with regard to novelty, quantity and
defense warrants a PhD degree with a good margin.” Professor Carsten Peterson
and Dr. Salvarore Spicuglia, main opponents.
-
PhD supervisor of Thiago S. Guzella and Inês Trancoso.
PhD supervisor of Clara F. Pereira.
In the jury the evaluated the Ph.D. thesis Estudio de la Especificidad Funcional de
-
AID en el proceso de hipermutación Somática (Universida Autónoma de Madrid,
2012), by Pablo Pérez Durán;
Masters’ supervisor of Daniel Espadinha (graduated with a 19/20 score).
In the jury the evaluated the Ph.D. thesis Dissecting the Complex Genetics of
Human Immune Deficiency (FCUL, 2010), by Ricardo Chaves Ferreira.
In the jury the evaluated the Ph.D. thesis Homeostasis of the T cell memory
compartment (FCUL, 2008), by Catarina Leitão.
RESEARCH EXPERIENCE
2015Principal Investigator at CEDOC (Nova Medical School).
2008-15
Principal Investigator at the Instituto Gulbenkian de Ciência.
2001-7
Postdoctoral research associate/Research Associate Molecular Immunology
Rockefeller University, New York, EUA (Laboratory of Dr. Michel C.
Nussenzweig).
2000-1
Collaborative work in the laboratory of Dr Jocelyne Demengeot. Instituto
Gulbenkian de Ciência, Oeiras, Portugal.
1996-1
PhD student (follow up of the initial project) Unité du Développement des
Lymphocytes, Institut Pasteur, Paris, France (Laboratory of Drª Ana Cumano).
1995-6
PhD student
Unité d’Immunogénétique, Institut Pasteur, Paris, France.
(Laboratory of Prof. Tommaso Meo).
1994
Erasmus student Centre de Génétique Moléculaire, C.N.R.S. de Gif-Sur-Yvette,
France (Laboratory of Dr. Roger Karess).
DISTINTIONS, SCHOLARSHIPS & AWARDS
2015FCT Investigator Development Grant.
2002-03
Postdoctoral scholarship from the Fundação para a Ciência e Tecnologia,
Portugal.
1999-00
Scholarship from the Ligue Française pour la Recherche.
1995-99
Scholarship from the Gulbenkian Foundation-Praxis Program Portugal.
1995
Award from the Universidade de Lisboa for Academic Achievement.
1995
Erasmus program fellow.
FUNDING
2018
Funds to generate genetically engineered mice strains at the Instituto Gulbenkian
de Ciência in collaboration with Dr. Alberto Nóbrega (Universidade Federal do
Rio de Janeiro). 10 000 €
2018
UCDP award recipient to Dr. Jacobus Hendricks, who will develop work in my
group for a short period and has a stipend for reagents (3 months, 2000 €).
2015
Epigenetics and Genetics of Hematopoietic Stem Cell Heterogeneity FCT
PTDC/BEX-BCM/5900/2014 (36 months, 195 072 €).
2014
Activation-Induced Cytidine Deaminase as a Guardian of the Genome (12
months, 50 000 €) FCT Investigator Development Grant.
2012
Targets and off-targets of the lymphocytes recombinase PTDC/BIAGEN/116830/2010 (175 188 €) – Jocelyne Demengeot (IGC) is the responsible
PI.
2010
FCT: On the epigenetic nature of Ig gene Monoallelic Expression PTDC/BIABCM/108020/2008 (195 000 €).
-
Marie Curie Reintegration Grant: AID and Beyond PIRG03-GA-
(100 000 €).
Terry Fox/LPCC: Directed Evolution of AID (15 000 €).
APCL: AID in Chronic Lymphocytic Leukemia (40 000 €).
SCIENCE (COMMUNICATION) ACTIVITIES
2016
Chairman of the Development & Differentiation Session of the “Immunity, from
Cells to Organisms” SPI 2016 Meeting, IGC, Portugal
2013Freelance scientific editor for American Journal Experts, Cactus
Global,
Compuscript and Cambridge YPE. Over 160 edited manuscripts (563K words)
and 19 translated manuscripts (85K words).
2012
Columnist
for
the
newspaper
“i”
[in
Portuguese]:
http://www.ionline.pt/autor/vasco-barreto
2011-13
Moderator of public debates for the Fundação Francisco Manuel dos Santos [in
Portuguese]: http://www.ffms.pt/lista/actividade/13/1
2008
Translation and adaptation for Portuguese of the book “Evolution”, by Daniel
Loxton (which was distributed on the occasion of the Darwin Exhibition
organized by the Gulbenkian Foundation).
2008
Columnist for the Portuguese’s edition of the newspaper Metro.
2005
“A Sketch of Portugal and its People” - article in the magazine Natural Selections
(The Rockefeller University).
2004-06
Founder of a science communication web page, ContaNatura.
PANELS & COMMITTEES
2016
Plants for Life board to select Ph.D. students.
2015
Editorial Board of Springer Plus.
2004Referee for the following scientific journals: Cell, Infection, Genetics and
Evolution, Journal of Experimental Medicine, Nature Methods (Nature), Nucleic
Acids Research, PlosOne, , Scientific Reports (Nature) and SpringerPlus.
2012
FCT panel to select postdoctoral applications
2009Thesis committee of 3 PhD student from the IGC-
Member of the Flow Cytometry Committee of the IGC
Panel to award a “Optimus Alive” fellowship
ORGANIZATION OF SCIENTIFIC MEETINGS
2018
AID workshop. Israel.
2008
Co-organizer of the 4th Gulbenkian Alumni Meeting: “Alternative Careers for
Scientists”
2000
Scientific organizer of the 3rd Gulbenkian Autumn Meeting on Cellular
Differentiation
COMMUNICATIONS IN MEETINGS
Vicente MM, Vicente J, Trancoso I, Barreto VM. The ubiquitin-conjugating enzyme (E2) UBE2W promotes class-switch recombination. Poster
presented at: Keystone Symposia Conference | B cells: Mechanism in Immunity and Autoimmunity. June 2018, Dresden, Germany
Santos D, Carneiro J, Athanaisatis A, Barreto VM, Trancoso I, Sobral D, Bonnet M, Demengeot J, Leal JP (poster). Prediction of recombination
signal sequences and their evolutionary history (2012). XXXVIII Annual Meeting of the Portuguese Society of Immunology: from immune
Disorders to immunotherapies, Porto, Portugal.
Pereira CF, Lopes, T, Gardner R, Vieira P, Barreto VM (poster). "Stochasticity and commitment in the V(D)J rearrangement of the murine IgH"
(2012). Keystone symposia: "Mutations, Malignancy and Memory, Antibodies and Immunity" Boston, USA.
Cortesao CS, Barreto VM (poster). AID Does Not Affect the Global Frequency of Meiotic Recombination in Mice (2012). Keystone
Symposium on Mutations, Malignancy and Memory - Antibodies and Immunity, Boston, USA.Trancoso I, Bonnet M, Gardner R, Carneiro J,
Barreto VM, Demengeot J, Sarmento LM (poster). A novel reporter assay for RAG targets and RAG activity (2012). Keystone Symposia
"Mutations, Malignancy and Memory - Antibodies and Immunity", Boston, USA.Pereira CF, Vieira P, Barreto VM (poster). Clonal Analysis of
V(D)J Rearrangement in Immunoglobulin Genes: Implications for Allelic Exclusion” (poster). Imprinting and beyond: “Mono-allelic Expression
in Health and Disease”(2011). Hospital St Santa Creu, Barcelona, Spain.Pereira CF, Vieira P, Barreto VM (poster). Clonal Analysis of V(D)J
rearrangement in immunoglobulin genes: implications for allelic exclusion (2011). Keystone Symposia Cells: New Insights into Normal versus
Dysregulated Function. Whistler, British Columbia, Canada
Pereira CF, Vieira P, Barreto VM (poster) Clonal Analysis of V(D)J Rearrangement in Immunoglobulin Genes: Implications for Allelic
Exclusion (2011) Keystone symposia, D2: Hematopoiesis, Big Sky Resort, Big Sky, Montana, USA.
Pereira CF, Vieira P, Barreto VM (poster). The Epigenetic Nature of Immunoglobulin Allelic Exclusion (2009). 2nd European Congress of
Immunology ECI Berlin, Germany.
Pereira CF, Vieira P, Barreto VM (poster). The Epigenetic Nature of Ig Gene Allelic Exclusion (2009). XXXV Reunião Annual da Sociedade
Portuguesa de Imunologia, September, Lisbon, Portugal
Reis PH, Caratão N, Jacob CM, Pastorino AC, Carneiro-Sampaio M, Barreto VM (poster) A New Activation-Induced Cytidine Deaminase
(AID) mutation in a Brasilian family (2009). The European Society for Immunodeficiencies (ESID) October 16-19, 13 th Meeting of,
Hertogenbosch, Netherlands.
Reis PH, Caratão N, Jacob CM, Pastorino AC, Carneiro-Sampaio M, Barreto VM (poster) A New Activation-Induced Cytidine Deaminase
(AID) mutation in a Brasilian family (2008). Portuguese Society for Immunology Annual Meeting, October 26-28, Porto, Portugal
Jankovic M, Barreto VM (poster) Nussenzweig M.C. Chromatin Remodeling in Rag locus (2005) Keystone Symposium on B cell Development,
Function and Disease, Colorado, USA.
Barreto V, Marques R, Demengeot J (poster). Early death and severe lymphopenia caused by ubiquitous expression of the Rag1 and Rag2 genes
in mice (2001). Keystone Symposium on B Lymphocyte Biology and Disease (April, 2001, Utah, USA).
Barreto V, Cumano A (poster). The frequency of Immunoglobulin allelic included cells in normal mice is in the order of 1 in 104 (1999)
Keystone Symposium in B Lymphocyte Biology and Disease, New Mexico, USA.
Barreto V, Meo T, Cumano A (poster). Ig heavy chain allelic exclusion: lessons from IgH tri-allelic mice and from dual expressors. (1998)
Journées Departementales d’Immunologie, session d’Automne, Institut Pasteur, Paris, France.
Barreto V, Karess R (poster). Pandora’s box: a Drosophila gene required for proper mitosis and oogenesis. (1994), Erasmus Intensive Course in
Genetics, Pavia, Italy.
COMMUNICATIONS IN MEETINGS OR RESEARCH INSTITUTIONS AS INVITED
SPEAKER
2018
Nas Fronteiras da Ciência: Limites e Representações. CEDOC DIA ABERTO,
June 30, 2018, CEDOC, Portugal
2018
“The mystique of Epigenetics” Jornadas Tecnológicas de Biologia (JorTec)
February 7-8 , 2018 FCT/Nova, Portugal
2018
On the C-terminus of AID. AID/APOBEC workshop 15-18 January 2018. Israel
2012
Os Mistérios da Epigenética (2012) Ciclo de Conferências 2012 Rethinking
Biology and Evolution, FCUL, Lisboa, Portugal.
2012
Physiologic Double-Strand Breaks (2012) CNIO, Madrid, Spain.
2011
A Short History of Ig Loci Allelic Exclusion and a Clonal Analysis of V(D)J
Rearrangement. SPI International Summer School of Immunology, Tavira,
Portugal
2010
A Clonal Analysis of V(D)J Rearrangement: Implications for Allelic Exclusion.
Instituto de Medicina Molecular, Portugal
2010
Functional analysis of the AID from a cartilaginous fish. AID workshop,
Stockholm, Sweden
2004
Keynote speaker in the Annual Meeting of the Portuguese immunology
Society, Oeiras, Portugal.
ORIGINAL PEER REVIEWED PUBLICATIONS
16. Guzella TS, Barreto VM*, Carneiro J* (2019) Partitioning stable and unstable expression
level variation in cell populations: a theoretical framework with application to the T cell receptor
BIORXIV/2019/527663 (Archived)
15. Santos, D, Bonnet M, Sobral, D, Trancoso, I, Silva J, Barreto, VM, Athanasiadis, A,
Demengeot J, Pereira-Leal J.B (2016). RAG recombinase as a pressure for genome evolution.
Genome Biology and Evolution doi:10.1093/gbe/evw261
14. Borges da Silva H, Fonseca R, Anjos Cassado A, Salles EM, Menezes MN, Langhorne J,
Perez KR , Cuccovia IM, Ryffel B, Barreto VM, Farias Marinho CR, Boscardin SB , Álvarez
JM, D’Império-Lima MR, Tadokoro CE. (2015) In vivo Approaches Reveal a Key Role for DCs
in CD4+ T Cell Activation and Parasite Clearance During the Acute Phase of Experimental
Blood-Stage Malaria. Plos Pathogens 11(2): e-. DOI: 10.1371/journal.ppat-. Pereira CF, Freitas R., Lopes T., Gardner R., Marta F., Vieira P., Barreto VM (2014)
Independent recruitment of Igh alleles in V(D)J recombination. Nature Communications 5: 5623
DOI:10.1038/ncomms6623
12. Caratão N, Cortesão CS, Reis PH, Freitas RF, Jacob CM, Pastorino AC, Carneiro-Sampaio
M, Barreto VM (2013) A novel activation-induced cytidine deaminase (AID) mutation in
Brazilian patients with hyper-IgM type 2 syndrome. Clin Immunol. 148(2):279-286. DOI:
10.1016/j.clim-. Trancoso I, Bonnet M, Gardner R, Carneiro J, Barreto VM, Demengeot J, Sarmento LM.
(2013) A Novel Quantitative Fluorescent Reporter Assay for RAG Targets and RAG Activity.
Front Immunol.16;4:110. DOI: 10.3389/fimmu-. Cortesao C S, Freitas RF, Barreto VM. (2013) Activation-Induced Cytidine Deaminase
Does Not Impact on Murine Meiotic Recombination G3 (Bethesda, Md.) 3:645-655 DOI:
10.1534/g-. Pavri R, Gazumyan A, Jankovic M, Di Virgilio M, Klein I, Ansarah-Sobrinho C, Resch W,
Yamane A, Reina San-Martin B, Barreto VM, Nieland TJ, Root DE, Casellas R, Nussenzweig
MC. (2010) Activation-induced cytidine deaminase targets DNA at sites of RNA polymerase II
stalling by interaction with Spt5. Cell 143(1):122-33 DOI: 10.1016/j.cell-. McBride KM, Gazumyan A, Woo EM, Barreto VM, Robbiani DF, Chait BT, Nussenzweig
MC. (2006) Regulation of hypermutation by activation-induced cytidine deaminase
phosphorylation. Proc Natl Acad Sci U S A. 6;103(23):- DOI:
10.1073/pnas-. Barreto VM, Pan-Hammarstrom Q, Zhao Y, Hammarstrom L, Misulovin Z, Nussenzweig
(2005) AID from bony fish catalyzes class switch recombination. Journal of Experimental
Medicine 202(6):733-8 DOI: 10.1084/jem-. McBride KM, Barreto V, Ramiro AR, Stavropoulos P, Nussenzweig MC. (2004). Somatic
Hypermutation Is Limited by CRM1-dependent Nuclear Export of Activation- induced
Deaminase. Journal of Experimental Medicine 199(9):1235-44 DOI: 10.1084/jem-. Yannoutsos N, Barreto V, Misulovin Z., Gazumyan A, Yu, W., Rajewsky, N., Peixoto, B.R.,
Eisenreich, T. and Nussenzeig, M.C. (2004) A cis element in the recombinase activating gene
locus regulates gene expression by counteracting a distant silencer. Nature Immunology
5(4):443-50 DOI: 10.1038/ni1053
4. Barreto, V, Reina-San-Martin, B, Ramiro, AR, McBride KM, and Nussenzweig MC (2003).
C-terminal deletion of AID uncouples class switch recombination from somatic hypermutation
and gene conversion. Molecular Cell 12,-. Barreto V, Marques R and Demengeot J (2001) Early death and severe lymphopenia caused
by ubiquitous expression of the Rag1 and Rag2 genes in mice. European Journal of Immunology.
31:- DOI: 10.1002/-:12<3763::AID-IMMU3763>3.0.CO;2-Y
2. Barreto, V., Meo, T. and Cumano, A. (2001) Mice tri-allelic for the IgH locus: implications
for VHDJH recombination. Journal of Immunology 166:- URL:
http://www.scopus.com/inward/record.url?eid=2-s-&partnerID=MN8TOARS
1. Barreto, V. and Cumano, A. (2000) Frequency and characterization of phenotypic Ig heavy
chain allelically included IgM-expressing B cells in mice. Journal of Immunology 164:893-9
URL:
http://www.scopus.com/inward/record.url?eid=2-s2.0-
-&partnerID=MN8TOARS
INVITED CHAPTERS, ORIGINAL REVIEWS IN PEER REVIEWED PUBLICATIONS
AND ADDITIONAL WRITTEN COMMUNICATIONS
9. Barreto, VM (2018) I.Q and “race” Electra. n 3.
8. Barreto, VM (2016), O mistério da epigenética. In: António Barbosa e Ricardo Santos (Eds.),
Questões de Vida - Estudos de Ciência & Filosofia. Lisboa: CFCUL. P-. Ramiro, A. and Barreto, VM (2015) Activation-induced cytidine deaminase and active
cytidine demethylation. Trends in Biochemical Sciences 40(3):172-81. DOI:
10.1016/j.tibs-. Barreto, VM. (2013) Comentário ao texto "Xadrez político", de M.C. Lobo. In Cardoso, J. L.,
Magalhães, P. e Pais, J. M. (Eds.), Portugal social de A a Z: temas em aberto (pp. 296-303).
Lisboa: Expresso / ICS
5. Barreto VM, Magor BG (2011). Activation-induced cytidine deaminase structure and
functions: A species comparative view. Dev Comp Immunol. 35(9):-. doi:
10.1016/j.dci-. Pastorino AC, Reis PH, Stefani GP, Caratao N, Jacob CMA, Barreto VM, Carneiro-Sampaio
M (2008) A new activation-induced cytidine deaminase (AID) mutation in a Brazilian family.
Clinical and Experimental Immunology (conference) Wiley-Blackwell Publishing, INC-. Ramiro A, San-Martin BR, McBride K, Barreto VM, Nussenzweig A, Nussenzweig MC.
(2007). The role of activation induced deaminase in antibody diversification and chromosome
translocations Advances in Immunology. 94:75-107.
2. Barreto V, Ramiro A, Nussenzweig MC (2005). Activation-induced deaminase: controversies
and open questions. Trends Immunol. 26(2):90-6. DOI: 10.1016/j.it-. Cumano A, Godin I, Delassus S, Dierterlen-Lièvre F, Barreto V (2000). Changes in lymphoid
Progenitor Populations During Mammalian Development In: Hematopoiesis: A Developmental
Approach, L. Zon editor. Oxford University Press
TRANSLATIONS AND ADAPTATIONS
1. Daniel Loxton/ translation and adaptation: Barreto VM (2009) A Evolução de Darwin.
Fundação Calouste Gulbenkian. 47 pages
shttp://catalogo.bnportugal.pt/ipac20/ipac.jsp?session=R380A-I.29074&profile=bn&uri=link=-~!-~!-~!-
&aspect=basic_search&menu=search&ri=1&source=~!bnp&term=Loxton%2C+Daniel&index=AUTHOR
OTHER PUBLICATIONS
6. Barreto VM (in press) O incesto em Eça e Nabokov. Revista Ler. Nº 154
5. Barreto VM (2017) Mediums da Depressão. Revista Ler. Nº 149
4. Gusmão, R. (ed), Barreto, V.M. (ed), Luzio, L.F. (ed). (in press) A promoção da saúde
mental e a prevenção da depressão e suicídio: foco estratégico na integração da saúde mental nos
cuidados de saúde primários. http://eulutocontraadepressao.eutimia.pt
3. Barreto VM (2013) Acesso Livre à Literatura Científica: Como e Quando? FCT newsletter N
4. http://newsletter.fct.pt/newsletter-4-cronica-convidada/
2. Barreto VM (2007) João, Sofia e Maria in Contos de Algibeira. Laís Chaffe (org.) Casa
Verde. 124 pages. http://www.casaverde.art.br
1. Barreto VM (2005) A Sketch of Portugal and its People. Natural Selections (The Rockefeller
University) Issue 18. selections.rockefeller.edu/wp-content/uploads/2012/07/ns-07-2005.pdf
